Difference between revisions of "British-American Tobacco"
(Covid "vaccine" from plants) |
(sponsors Institute for Fiscal Studies) |
||
| Line 4: | Line 4: | ||
|logo=British American Tobacco logo.svg | |logo=British American Tobacco logo.svg | ||
|start= | |start= | ||
| + | |sponsors=Institute for Fiscal Studies | ||
|headquarters=London, United Kingdom | |headquarters=London, United Kingdom | ||
|sourcewatch=http://www.sourcewatch.org/index.php/British-American_Tobacco | |sourcewatch=http://www.sourcewatch.org/index.php/British-American_Tobacco | ||
| Line 15: | Line 16: | ||
In December 2022, BAT's US Bio-tech arm, [[Kentucky BioProcessing]] (KBP) announced plans to commence a Phase I first-time-in-human study of its [[COVID-19]] vaccine candidate. According to the press release, the candidate vaccine has been developed using KBP's innovative fast-growing plant-based technology. This unique approach has a number of possible advantages, including the rapid production of the vaccine's active ingredients in around 6-weeks, compared to several months using conventional methods. The candidate vaccine also has the potential to be stable at room temperature. If successful, the speed of production of the active ingredients has the potential to reduce the time between identifying new viruses and strains, and vaccine development and deployment to those who need it.<ref>https://www.bat.com/media/press-releases/_2020/december/dec-16---bat-progresses-covid-19-candidate-vaccine-into-phase-i- [https://archive.is/wip/TFSOs archived]</ref> | In December 2022, BAT's US Bio-tech arm, [[Kentucky BioProcessing]] (KBP) announced plans to commence a Phase I first-time-in-human study of its [[COVID-19]] vaccine candidate. According to the press release, the candidate vaccine has been developed using KBP's innovative fast-growing plant-based technology. This unique approach has a number of possible advantages, including the rapid production of the vaccine's active ingredients in around 6-weeks, compared to several months using conventional methods. The candidate vaccine also has the potential to be stable at room temperature. If successful, the speed of production of the active ingredients has the potential to reduce the time between identifying new viruses and strains, and vaccine development and deployment to those who need it.<ref>https://www.bat.com/media/press-releases/_2020/december/dec-16---bat-progresses-covid-19-candidate-vaccine-into-phase-i- [https://archive.is/wip/TFSOs archived]</ref> | ||
| − | + | ==Sponsors== | |
| − | + | In the 1970s it financed the [[Institute for Fiscal Studies]] after a request from [[Dick Taverne]].<ref>https://www.industrydocuments.ucsf.edu/tobacco/docs/#id=rpjx0201</ref> | |
Latest revision as of 01:02, 16 December 2024
 British-American Tobacco  (Company)     | |
|---|---|
 | |
| Headquarters | London, United Kingdom |
| Subgroups | • Tekel • Bentoel Group • Souza Cruz • Niemeyer |
| Sponsor of | Institute for Fiscal Studies |
British-American Tobacco (BAT) has been part of many deep state activities over the years.
Covid "vaccines"
In December 2022, BAT's US Bio-tech arm, Kentucky BioProcessing (KBP) announced plans to commence a Phase I first-time-in-human study of its COVID-19 vaccine candidate. According to the press release, the candidate vaccine has been developed using KBP's innovative fast-growing plant-based technology. This unique approach has a number of possible advantages, including the rapid production of the vaccine's active ingredients in around 6-weeks, compared to several months using conventional methods. The candidate vaccine also has the potential to be stable at room temperature. If successful, the speed of production of the active ingredients has the potential to reduce the time between identifying new viruses and strains, and vaccine development and deployment to those who need it.[1]
Sponsors
In the 1970s it financed the Institute for Fiscal Studies after a request from Dick Taverne.[2]
Employee on Wikispooks
| Employee | Job | Appointed | End |
|---|---|---|---|
| Peter Macadam | Chairman | 1976 | 1982 |
